Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 61 entries
View as:

Prospective Evaluation of Iron Status in Cancer Patients Beginning Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01968304 Org: User:
Start: 09/30/13 End: 04/30/16 Due: 04/30/17

Study of Cerebral Vascular Reserve Using Pharmacological Testing With Acetazolamide: A Non-Inferiority Study of PET Method Compared to Conventional Reference Scintigraphy

Phase: N/A Priority: Normal
NCT ID: NCT06584747 Org: User:
Start: 10/31/24 End: 10/31/26 Due: 10/31/27

Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00953537 Org: User:
Start: 01/31/09 End: 02/28/11 Due: 02/28/12

Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA

Phase: N/A Priority: Normal
NCT ID: NCT06606366 Org: User:
Start: 03/03/25 End: 06/03/27 Due: 06/03/28

Trastuzumab in Treating Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00896376 Org: User:
Start: 12/31/05 End: 09/30/10 Due: 09/30/11

COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID)

Phase: N/A Priority: Normal
NCT ID: NCT04492410 Org: User:
Start: 07/21/20 End: 11/12/21 Due: 11/12/22

Consequences of an Initial Treatment for Head and Neck Cancer on Swallowing Function: Impact on Nutritional Status

Phase: N/A Priority: Normal
NCT ID: NCT03068559 Org: User:
Start: 12/20/12 End: 09/15/16 Due: 09/15/17

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00690560 Org: User:
Start: 05/31/07 End: 10/31/10 Due: 10/31/11

Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient

Phase: N/A Priority: Normal
NCT ID: NCT02467946 Org: User:
Start: 01/14/16 End: 04/06/22 Due: 04/06/23

Individual Food Preferences for the Mediterranean Diet in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06058312 Org: User:
Start: 09/04/23 End: 09/04/24 Due: 09/04/25

Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03121469 Org: User:
Start: 10/25/18 End: 06/10/25 Due: 06/10/26

Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)

Phase: N/A Priority: Normal
NCT ID: NCT02022800 Org: User:
Start: 11/30/13 End: 06/30/16 Due: 06/30/17

Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00875849 Org: User:
Start: 03/31/08 End: 12/31/13 Due: 12/31/14

18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03584334 Org: User:
Start: 04/04/19 End: 04/30/25 Due: 04/30/26

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06029218 Org: User:
Start: 09/13/23 End: 10/01/31 Due: 10/01/32

Sunitinib Malate in Treating Patients With Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00943839 Org: User:
Start: 02/28/09 End: 12/31/14 Due: 12/31/15

Study of the Impact of DPD Activity on the Efficacy of Capecitabine

Phase: N/A Priority: Normal
NCT ID: NCT04198727 Org: User:
Start: 07/20/20 End: 07/31/30 Due: 07/31/31

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)

Phase: N/A Priority: Normal
NCT ID: NCT05664893 Org: User:
Start: 06/26/23 End: 03/31/33 Due: 03/31/34

Phase I Trial of CArbonic Anhydrase Inhibition in Combination with Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03467360 Org: User:
Start: 08/02/19 End: 04/27/27 Due: 04/27/28

Conventional Oxygen Therapy Versus Continuous Transnasal High Flow Oxygen Therapy for Head and Neck Diagnostic Panendoscopy Under General Anesthesia in Spontaneous Ventilation

Phase: N/A Priority: Normal
NCT ID: NCT05696288 Org: User:
Start: 04/12/23 End: 10/12/25 Due: 10/12/26

Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)

Phase: N/A Priority: Normal
NCT ID: NCT03548428 Org: User:
Start: 06/04/20 End: 02/04/31 Due: 02/04/32

Hypofractionated Radiation by CyberKnife as a Mean of the Tumor Site's Radiation After Conventional Breast Radiation.

Phase: N/A Priority: Normal
NCT ID: NCT02867423 Org: User:
Start: 02/28/11 End: 07/31/18 Due: 07/31/19

Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Phase: N/A Priority: Normal
NCT ID: NCT01858441 Org: User:
Start: 04/30/13 End: 12/03/20 Due: 12/03/21

POSitron Emission Imaging Using 18F-FDOPA in Neurooncology

Phase: N/A Priority: Normal
NCT ID: NCT02631655 Org: User:
Start: 12/31/15 End: 06/30/20 Due: 06/30/21

A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03371550 Org: User:
Start: 08/05/04 End: 10/31/11 Due: 10/31/12